ARCHIVES

FDA Committee Approves NDA for Mitxantrone

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

NCI, Groups Disagree Over repayment, McIntyre: NCA Could Examine Relationship of Groups To NCI

December 9, 1994

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

NCAB Delays Decision On Organ Site Program Until May Meeting

February 12, 1982

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983

In Turnaround, HHS Says It Will Enforce Pediatric Rule

April 26, 2002